• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者脑死后黑质中铁(III)及总铁含量增加。

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

作者信息

Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds G P, Hebenstreit G, Youdim M B

机构信息

Department of Psychiatry, University of Würzburg, Federal Republic of Germany.

出版信息

J Neural Transm. 1988;74(3):199-205. doi: 10.1007/BF01244786.

DOI:10.1007/BF01244786
PMID:3210014
Abstract

Significant differences in the content of iron (III) and total iron were found in post mortem substantia nigra of Parkinson's disease. There was an increase of 176% in the levels of total iron and 225% of iron (III) in the substantia nigra of the parkinsonian patients compared to age matched controls. In the cortex (Brodmann area 21), hippocampus, putamen, and globus pallidus there was no significant difference in the levels of iron (III) and total iron. Thus the changes in total iron, iron (III) and the iron (II)/iron (III) ratio in the parkinsonian substantia nigra are likely to be involved in the pathophysiology and treatment of this disorder.

摘要

在帕金森病患者死后的黑质中发现铁(III)和总铁含量存在显著差异。与年龄匹配的对照组相比,帕金森病患者黑质中的总铁水平增加了176%,铁(III)水平增加了225%。在皮质(布罗德曼21区)、海马体、壳核和苍白球中,铁(III)和总铁水平没有显著差异。因此,帕金森病患者黑质中总铁、铁(III)以及铁(II)/铁(III)比值的变化可能与该疾病的病理生理学和治疗有关。

相似文献

1
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.帕金森病患者脑死后黑质中铁(III)及总铁含量增加。
J Neural Transm. 1988;74(3):199-205. doi: 10.1007/BF01244786.
2
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.帕金森病中黑质铁含量增加及大脑中其他金属离子的改变。
J Neurochem. 1989 Jun;52(6):1830-6. doi: 10.1111/j.1471-4159.1989.tb07264.x.
3
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.帕金森病患者大脑中的过渡金属、铁蛋白、谷胱甘肽和抗坏血酸。
J Neurochem. 1989 Feb;52(2):515-20. doi: 10.1111/j.1471-4159.1989.tb09150.x.
4
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.帕金森病大脑黑质致密部铁的选择性增加。
J Neurochem. 1991 Mar;56(3):978-82. doi: 10.1111/j.1471-4159.1991.tb02017.x.
5
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.血清铜蓝蛋白水平降低特征性地加重帕金森病患者的黑质铁沉积。
Brain. 2011 Jan;134(Pt 1):50-8. doi: 10.1093/brain/awq319. Epub 2010 Nov 24.
6
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.与神经黑色素相关的氧化还原活性铁在帕金森病患者的黑质中增加。
J Neurochem. 2003 Sep;86(5):1142-8. doi: 10.1046/j.1471-4159.2003.01923.x.
7
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.帕金森病患者黑质中铁和铝含量增加:X射线微分析
J Neurochem. 1991 Feb;56(2):446-51. doi: 10.1111/j.1471-4159.1991.tb08170.x.
8
Controversies about iron in parkinsonian and control substantia nigra.帕金森病患者与对照者黑质中铁元素的争议
Acta Neurobiol Exp (Wars). 1997;57(3):217-25. doi: 10.55782/ane-1997-1229.
9
Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.帕金森病患者的血清胆固醇和黑质纹状体 R2* 值。
PLoS One. 2012;7(4):e35397. doi: 10.1371/journal.pone.0035397. Epub 2012 Apr 17.
10
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.帕金森病及其他影响基底神经节的神经退行性疾病中铁、铁蛋白和其他微量金属水平的变化。
Brain. 1991 Aug;114 ( Pt 4):1953-75. doi: 10.1093/brain/114.4.1953.

引用本文的文献

1
Biological Characterization of the Anti-ferroptotic Properties of a Novel Anti-Parkinsonian Iron (II) Selective Dopamine Agonist, D-583.新型抗帕金森铁(II)选择性多巴胺激动剂D-583抗铁死亡特性的生物学表征
Neurochem Res. 2025 Aug 13;50(4):264. doi: 10.1007/s11064-025-04508-6.
2
Single-cell multiomics identifies both shared and unique features of immune dysfunction in Parkinson's disease and inflammatory bowel disease colon, plasma and stool.单细胞多组学揭示了帕金森病和炎症性肠病在结肠、血浆和粪便中免疫功能障碍的共同特征和独特特征。
bioRxiv. 2025 Jun 11:2025.04.29.651228. doi: 10.1101/2025.04.29.651228.
3
Iron and selenium: At the crossroads of development and death in oligodendrocytes.

本文引用的文献

1
HYDROXYLATION OF PHENYLALANINE BY PURIFIED PREPARATIONS OF ADRENAL AND BRAIN TYROSINE HYDROXYLASE.肾上腺和脑酪氨酸羟化酶纯化制剂对苯丙氨酸的羟化作用
Biochem Biophys Res Commun. 1965 Feb 17;18:482-8. doi: 10.1016/0006-291x(65)90778-3.
2
Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay.
Clin Chim Acta. 1981 Feb 5;109(3):305-11. doi: 10.1016/0009-8981(81)90316-8.
3
Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue.关于帕金森病的研究,包括对福尔马林固定脑组织的X射线荧光光谱分析。
铁与硒:少突胶质细胞发育与死亡的十字路口
Arch Biochem Biophys. 2025 Sep;771:110509. doi: 10.1016/j.abb.2025.110509. Epub 2025 Jun 13.
4
Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson's Disease.热量限制模拟物作为间充质干细胞分泌组的启动剂,以增强对帕金森病的再生反应。
Molecules. 2025 May 22;30(11):2260. doi: 10.3390/molecules30112260.
5
GATA Transcription Factors: A Cross-Road for Erythropoiesis, Neurodevelopment, and Synucleinopathies.GATA转录因子:红细胞生成、神经发育和突触核蛋白病的交叉点
Dev Neurobiol. 2025 Jul;85(3):e22975. doi: 10.1002/dneu.22975.
6
On the Potential Role of Phytate Against Neurodegeneration: It Protects Against Fe-Catalyzed Degradation of Dopamine and Ascorbate and Against Fe-Induced Protein Aggregation.植酸盐在对抗神经退行性变中的潜在作用:它可保护多巴胺和抗坏血酸免受铁催化的降解以及铁诱导的蛋白质聚集。
Int J Mol Sci. 2025 May 16;26(10):4799. doi: 10.3390/ijms26104799.
7
Nigrostriatal iron accumulation in the progression of Parkinson's disease.帕金森病进展过程中黑质纹状体铁蓄积
NPJ Parkinsons Dis. 2025 Apr 11;11(1):72. doi: 10.1038/s41531-025-00911-6.
8
Longitudinal Changes of Quantitative Brain Tissue Properties Induced by Balance Training.平衡训练引起的定量脑组织特性的纵向变化。
Hum Brain Mapp. 2025 Mar;46(4):e70128. doi: 10.1002/hbm.70128.
9
Ferric Ammonium Citrate Reduces Claudin-5 Abundance and Function in Primary Mouse Brain Endothelial Cells.柠檬酸铁铵降低原代小鼠脑内皮细胞中Claudin-5的丰度和功能。
Pharm Res. 2025 Feb;42(2):319-334. doi: 10.1007/s11095-025-03826-2. Epub 2025 Feb 12.
10
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.神经退行性疾病中铁及其他金属离子的稳态与代谢
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
J Neuropathol Exp Neurol. 1968 Jan;27(1):1-14. doi: 10.1097/00005072-196801000-00001.
4
[Trace elements in human brain. II. Copper, zinc, calcium and magnesium of 13 brain areas compared to iron during the 4th to 8th life decade (author's transl)].人脑中的微量元素。II. 与4至8个生命十年期间的铁相比,13个脑区的铜、锌、钙和镁(作者译)
Z Neurol. 1974 Feb 27;206(2):117-28.
5
[Trace elements in human brain. Iron concentration of 13 brain areas as a function of age].
Z Neurol. 1972;202(4):331-8.
6
Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.帕金森叠加综合征:利用脑铁的高场磁共振成像进行诊断
Radiology. 1986 May;159(2):493-8. doi: 10.1148/radiology.159.2.3961182.
7
Iron, a new aid in the treatment of Parkinson patients.
J Neural Transm. 1986;67(3-4):287-92. doi: 10.1007/BF01243354.
8
Iron in the brain: implications for Parkinson's and Alzheimer's diseases.大脑中的铁:对帕金森病和阿尔茨海默病的影响。
Mt Sinai J Med. 1988 Jan;55(1):97-101.
9
Biochemical fundamentals of Parkinson's disease.
Mt Sinai J Med. 1988 Jan;55(1):21-8.
10
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.帕金森病患者大脑中的过渡金属、铁蛋白、谷胱甘肽和抗坏血酸。
J Neurochem. 1989 Feb;52(2):515-20. doi: 10.1111/j.1471-4159.1989.tb09150.x.